28th Jan 2021 14:42
Avacta Group PLC - Wetherby, England-based pre-clinical stage biotechnology company - Enters into collaboration with Massachusetts-based Bruker Corp to assess SARS-CoV-2 assay Avacta developed alongside Adeptrix Inc, also based in Massachusetts. "Bruker is one of the world's leading analytical instrumentation companies providing high-performance scientific instruments and high-value analytical and diagnostic solutions to scientists globally," Avacta says.
Current stock price: 125.90 pence, down 7.4% on Thursday
Year-to-date change: up 10%
By Eric Cunha; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Avacta Group